These data suggest that alterations in levels or localization of FG nucleoporins, Ran and/or KPNBs could trigger tau pathology—and vice versa—and lead to the cellular and molecular phenotypes already observed in transgenic mouse models of FTD-Tau.60 This evidence concerns the gene MAPT and frontotemporal dementia.